Raymond James Financial Services Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $235K | Buy |
+3,273
| New | +$235K | ﹤0.01% | 3077 |
|
|
2024
Q2 | – | Sell |
-3,329
| Closed | -$267K | – | 3413 |
|
|
2024
Q1 | $267K | Buy |
3,329
+157
| +5% | +$12.6K | ﹤0.01% | 2910 |
|
|
2023
Q4 | $347K | Buy |
3,172
+77
| +2% | +$8.43K | ﹤0.01% | 2638 |
|
|
2023
Q3 | $312K | Buy |
3,095
+140
| +5% | +$14.1K | ﹤0.01% | 2621 |
|
|
2023
Q2 | $402K | Buy |
2,955
+6
| +0.2% | +$815 | ﹤0.01% | 2475 |
|
|
2023
Q1 | $306K | Sell |
2,949
-102
| -3% | -$10.6K | ﹤0.01% | 2629 |
|
|
2022
Q4 | $270K | Hold |
3,051
| – | – | ﹤0.01% | 2660 |
|
|
2022
Q3 | $245K | Sell |
3,051
-46
| -1% | -$3.69K | ﹤0.01% | 2715 |
|
|
2022
Q2 | $297K | Sell |
3,097
-11
| -0.4% | -$1.06K | ﹤0.01% | 2593 |
|
|
2022
Q1 | $462K | Buy |
3,108
+118
| +4% | +$17.5K | ﹤0.01% | 2431 |
|
|
2021
Q4 | $424K | Sell |
2,990
-26
| -0.9% | -$3.69K | ﹤0.01% | 2477 |
|
|
2021
Q3 | $395K | Buy |
3,016
+104
| +4% | +$13.6K | ﹤0.01% | 2505 |
|
|
2021
Q2 | $400K | Buy |
2,912
+154
| +6% | +$21.2K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $360K | Sell |
2,758
-94
| -3% | -$12.3K | ﹤0.01% | 2506 |
|
|
2020
Q4 | $319K | Buy |
+2,852
| New | +$319K | ﹤0.01% | 2421 |
|